


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 20 Jul 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil(R)
HSMN NewsFeed - 20 Jul 2007
Auriga Laboratories Appoints Lisa Tripodi as Vice President of Trade Relations
Auriga Laboratories Appoints Lisa Tripodi as Vice President of Trade Relations
HSMN NewsFeed - 20 Jul 2007
Meda Enters the US Market Through the Strategic Acquisition of MedPointe Inc
Meda Enters the US Market Through the Strategic Acquisition of MedPointe Inc
HSMN NewsFeed - 19 Jul 2007
NUCRYST Pharmaceuticals receives FDA clearance of antimicrobial barrier topical cream
NUCRYST Pharmaceuticals receives FDA clearance of antimicrobial barrier topical cream
HSMN NewsFeed - 19 Jul 2007
Genzyme Announces Phase 3 Trial of Mozobil in non-Hodgkin's Lymphoma Meets Primary Endpoint
Genzyme Announces Phase 3 Trial of Mozobil in non-Hodgkin's Lymphoma Meets Primary Endpoint
HSMN NewsFeed - 19 Jul 2007
Ortho-McNeil, Inc. Settles Patent Infringement Litigation Against Par/Kali
Ortho-McNeil, Inc. Settles Patent Infringement Litigation Against Par/Kali
HSMN NewsFeed - 19 Jul 2007
Par Pharmaceutical Announces Agreement with Ortho-McNeil to Settle Ultracet(R) Patent Litigation
Par Pharmaceutical Announces Agreement with Ortho-McNeil to Settle Ultracet(R) Patent Litigation
HSMN NewsFeed - 19 Jul 2007
Antares Announces Worldwide Development and License Agreement with Jazz Pharmaceuticals
Antares Announces Worldwide Development and License Agreement with Jazz Pharmaceuticals
HSMN NewsFeed - 19 Jul 2007
EpiCept Establishes Direct Licensing Agreement with Dalhousie University for EpiCept(TM) NP-1
EpiCept Establishes Direct Licensing Agreement with Dalhousie University for EpiCept(TM) NP-1
HSMN NewsFeed - 18 Jul 2007
Pivotal CIMZIA(TM) Data in Crohn's Disease Published in New England Journal of Medicine
Pivotal CIMZIA(TM) Data in Crohn's Disease Published in New England Journal of Medicine
HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
HSMN NewsFeed - 18 Jul 2007
Medarex Announces Initiation by Licensing Partner of Phase III Clinical Trial for Muckle Wells Syndrome
Medarex Announces Initiation by Licensing Partner of Phase III Clinical Trial for Muckle Wells Syndrome
HSMN NewsFeed - 17 Jul 2007
Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis
Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis
HSMN NewsFeed - 17 Jul 2007
William P. Kane Named Vice President, Commercial Operations for Keryx Biopharmaceuticals, Inc.
William P. Kane Named Vice President, Commercial Operations for Keryx Biopharmaceuticals, Inc.
HSMN NewsFeed - 17 Jul 2007
Encysive Pharmaceuticals Retains Morgan Stanley to Assist in Review of Strategic Alternatives
Encysive Pharmaceuticals Retains Morgan Stanley to Assist in Review of Strategic Alternatives
HSMN NewsFeed - 17 Jul 2007
Basilea Announces Filing of New Drug Submission in Canada for Ceftobiprole
Basilea Announces Filing of New Drug Submission in Canada for Ceftobiprole
HSMN NewsFeed - 16 Jul 2007
CV Therapeutics Names Lewis Stuart Senior Vice President, Commercial Operations
CV Therapeutics Names Lewis Stuart Senior Vice President, Commercial Operations
HSMN NewsFeed - 16 Jul 2007
Barr Confirms Patent Challenge of Xopenex(R) Inhalation Solution, 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL
Barr Confirms Patent Challenge of Xopenex(R) Inhalation Solution, 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL
HSMN NewsFeed - 16 Jul 2007
Dr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of Directors
Dr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of Directors
HSMN NewsFeed - 16 Jul 2007
Sciele Pharma Acquires a Novel, Patented Treatment for Head Lice from Summers Laboratories, Inc.
Sciele Pharma Acquires a Novel, Patented Treatment for Head Lice from Summers Laboratories, Inc.
HSMN NewsFeed - 13 Jul 2007
Valopicitabine Development Program Placed on Clinical Hold in the United States
Valopicitabine Development Program Placed on Clinical Hold in the United States
HSMN NewsFeed - 12 Jul 2007
Resverlogix Corp.: Dr. Roger Newton, Co-Discoverer of Lipitor(R), Commences his Board of Directors Position
Resverlogix Corp.: Dr. Roger Newton, Co-Discoverer of Lipitor(R), Commences his Board of Directors Position
HSMN NewsFeed - 12 Jul 2007
Xechem International Announces Change in Its CEO; Offers Update on Nigerian Operations
Xechem International Announces Change in Its CEO; Offers Update on Nigerian Operations
HSMN NewsFeed - 12 Jul 2007
Circassia Announces Acquisition of Organ Transplant Anti-Rejection Technology
Circassia Announces Acquisition of Organ Transplant Anti-Rejection Technology
HSMN NewsFeed - 12 Jul 2007
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals to Market CLONICEL(R)
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals to Market CLONICEL(R)
HSMN NewsFeed - 12 Jul 2007
Barrier Therapeutics Announces Positive Phase 2 Data With Oral Rambazole in Moderate to Severe Psoriasis
Barrier Therapeutics Announces Positive Phase 2 Data With Oral Rambazole in Moderate to Severe Psoriasis
HSMN NewsFeed - 12 Jul 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
HSMN NewsFeed - 12 Jul 2007
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
HSMN NewsFeed - 11 Jul 2007
ProEthic Pharmaceuticals Enters Into U.S. Licensing and Distribution Agreement for Lipofen
ProEthic Pharmaceuticals Enters Into U.S. Licensing and Distribution Agreement for Lipofen
HSMN NewsFeed - 11 Jul 2007
J. William Freytag, PH.D. appointed Chairman and Chief Executive Officer of Aspreva Pharmaceuticals
J. William Freytag, PH.D. appointed Chairman and Chief Executive Officer of Aspreva Pharmaceuticals
HSMN NewsFeed - 11 Jul 2007
Trius Therapeutics Recruits Former J&J Clinician as Chief Medical Officer
Trius Therapeutics Recruits Former J&J Clinician as Chief Medical Officer
HSMN NewsFeed - 11 Jul 2007
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
HSMN NewsFeed - 11 Jul 2007
Labopharm Completes South Korean Licensing and Distribution Agreement for Once-Daily Tramadol
Labopharm Completes South Korean Licensing and Distribution Agreement for Once-Daily Tramadol
HSMN NewsFeed - 10 Jul 2007
Synovics Pharmaceuticals Appoints Steven Getraer as Executive Vice President and Chief Financial Officer
Synovics Pharmaceuticals Appoints Steven Getraer as Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 10 Jul 2007
Ranbaxy Receives Final Approval To Manufacture and Market Amlodipine Besylate Tablets
Ranbaxy Receives Final Approval To Manufacture and Market Amlodipine Besylate Tablets
HSMN NewsFeed - 10 Jul 2007
Cipher Pharmaceuticals enters into U.S. licensing and distribution agreement for Lipofen
Cipher Pharmaceuticals enters into U.S. licensing and distribution agreement for Lipofen
HSMN NewsFeed - 10 Jul 2007
Pipex Pharmaceuticals Acquires Late-Stage Oral Candidate for Dry Age-Related Macular Degeneration (AMD)
Pipex Pharmaceuticals Acquires Late-Stage Oral Candidate for Dry Age-Related Macular Degeneration (AMD)
HSMN NewsFeed - 10 Jul 2007
Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR(TM) In Postherpetic Neuralgia
Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR(TM) In Postherpetic Neuralgia
HSMN NewsFeed - 10 Jul 2007
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
Noven to Acquire JDS Pharmaceuticals, Expanding Business Model & Broadening Product Pipeline
HSMN NewsFeed - 9 Jul 2007
Corcept Therapeutics Receives Orphan Drug Designation for CORLUX(R) Treatment of Cushing's Syndrome
Corcept Therapeutics Receives Orphan Drug Designation for CORLUX(R) Treatment of Cushing's Syndrome
HSMN NewsFeed - 9 Jul 2007
Pro-Pharmaceuticals Updates Progress of Clinical Trials & DAVANAT(R) 505 (b)(2) Filings
Pro-Pharmaceuticals Updates Progress of Clinical Trials & DAVANAT(R) 505 (b)(2) Filings
HSMN NewsFeed - 9 Jul 2007
World's First Therapeutic Vaccine for Brain Cancer Commercially Available to Patients in Switzerland
World's First Therapeutic Vaccine for Brain Cancer Commercially Available to Patients in Switzerland
HSMN NewsFeed - 6 Jul 2007
Cobalis Reports Phase III Trial Results for PreHistin(TM) in Seasonal Allergic Rhinitis
Cobalis Reports Phase III Trial Results for PreHistin(TM) in Seasonal Allergic Rhinitis
HSMN NewsFeed - 5 Jul 2007
ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
HSMN NewsFeed - 5 Jul 2007
Auriga Laboratories Appoints Rick Coulon Vice President of Consumer Brands
Auriga Laboratories Appoints Rick Coulon Vice President of Consumer Brands
HSMN NewsFeed - 5 Jul 2007
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
Aradigm Corporation Names Norman Halleen as Interim Chief Financial Officer
HSMN NewsFeed - 4 Jul 2007
Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics
Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics
HSMN NewsFeed - 4 Jul 2007
Circassia Announces the Appointment of Sir Richard Sykes as Chairman of the Board
Circassia Announces the Appointment of Sir Richard Sykes as Chairman of the Board
HSMN NewsFeed - 3 Jul 2007
BioForm Strengthens Management Team With Three Leading Industry Executives
BioForm Strengthens Management Team With Three Leading Industry Executives
HSMN NewsFeed - 3 Jul 2007
Dong Wha and Procter & Gamble Pharmaceuticals Form Alliance for Osteoporosis Treatments
Dong Wha and Procter & Gamble Pharmaceuticals Form Alliance for Osteoporosis Treatments
HSMN NewsFeed - 3 Jul 2007
Mentor Announces Initial Patient Injections in Phase III Study for PurTox(R) Botulinum Toxin Type A
Mentor Announces Initial Patient Injections in Phase III Study for PurTox(R) Botulinum Toxin Type A
HSMN NewsFeed - 3 Jul 2007
Par Pharmaceutical Licenses U.S. Commercialization Rights to Loramyc(TM) From BioAlliance Pharma
Par Pharmaceutical Licenses U.S. Commercialization Rights to Loramyc(TM) From BioAlliance Pharma
HSMN NewsFeed - 3 Jul 2007
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
HSMN NewsFeed - 3 Jul 2007
AVANIR Pharmaceuticals Announces Sale of FazaClo to Fund Continued Development of Zenvia
AVANIR Pharmaceuticals Announces Sale of FazaClo to Fund Continued Development of Zenvia
HSMN NewsFeed - 2 Jul 2007
Tamiflu(R) 30 mg and 45 mg Capsules Approved by U.S. Food and Drug Administration
Tamiflu(R) 30 mg and 45 mg Capsules Approved by U.S. Food and Drug Administration
HSMN NewsFeed - 2 Jul 2007
PDI Announces New $23 Million Contract Sales Engagement with Top-Five Pharmaceutical Company
PDI Announces New $23 Million Contract Sales Engagement with Top-Five Pharmaceutical Company
HSMN NewsFeed - 2 Jul 2007
Valeant Pharmaceuticals Settles Suit with Kali Laboratories on Diastat Generic Challenge
Valeant Pharmaceuticals Settles Suit with Kali Laboratories on Diastat Generic Challenge
HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
HSMN NewsFeed - 2 Jul 2007
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
HSMN NewsFeed - 29 Jun 2007
Shire Announces Filing of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults
Shire Announces Filing of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults
HSMN NewsFeed - 29 Jun 2007
Breckenridge Pharmaceutical, Inc. and Chemo/Liconsa (Spain) Agree to Develop and Market Generic ANDA
Breckenridge Pharmaceutical, Inc. and Chemo/Liconsa (Spain) Agree to Develop and Market Generic ANDA
HSMN NewsFeed - 29 Jun 2007
Merck Names Peter Kellogg as Executive Vice President and Chief Financial Officer
Merck Names Peter Kellogg as Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 29 Jun 2007
Mymetics Expands Board of Directors with the Addition of Dr. Thomas Staehelin
Mymetics Expands Board of Directors with the Addition of Dr. Thomas Staehelin
HSMN NewsFeed - 29 Jun 2007
Wyeth Announces Election of Mary Katherine Wold as Senior Vice President, Finance
Wyeth Announces Election of Mary Katherine Wold as Senior Vice President, Finance
HSMN NewsFeed - 29 Jun 2007
Bayer HealthCare Announces New 2000 IU Vial Size for Kogenate(R) FS Treatments
Bayer HealthCare Announces New 2000 IU Vial Size for Kogenate(R) FS Treatments
HSMN NewsFeed - 29 Jun 2007
Indevus Appoints Industry Veteran Kurt Lewis as Senior Vice President Sales & Marketing
Indevus Appoints Industry Veteran Kurt Lewis as Senior Vice President Sales & Marketing
HSMN NewsFeed - 29 Jun 2007
Labopharm meets with FDA to discuss second Approvable Letter for once-daily tramadol
Labopharm meets with FDA to discuss second Approvable Letter for once-daily tramadol
HSMN NewsFeed - 28 Jun 2007
Coley Pharmaceutical Group Grants Dynavax License for Commercialization of HEPLISAV(TM)
Coley Pharmaceutical Group Grants Dynavax License for Commercialization of HEPLISAV(TM)
HSMN NewsFeed - 28 Jun 2007
INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of Schizophrenia
HSMN NewsFeed - 28 Jun 2007
Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)
Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)
HSMN NewsFeed - 28 Jun 2007
Advancis Pharmaceutical Changes Its Name to MiddleBrook Pharmaceuticals, Inc.
Advancis Pharmaceutical Changes Its Name to MiddleBrook Pharmaceuticals, Inc.
HSMN NewsFeed - 28 Jun 2007
Pfizer Initiates Phase III Trial to Study Sunitinib Malate in Patients with Metastatic Colorectal Cancer
Pfizer Initiates Phase III Trial to Study Sunitinib Malate in Patients with Metastatic Colorectal Cancer
HSMN NewsFeed - 27 Jun 2007
NUCRYST Pharmaceuticals appoints Katherine J. Turner, PhD to Vice President, Research and Development
NUCRYST Pharmaceuticals appoints Katherine J. Turner, PhD to Vice President, Research and Development
HSMN NewsFeed - 27 Jun 2007
DURECT Announces the Initiation of Sufentanil Patch Phase II Study by Endo Pharmaceuticals
DURECT Announces the Initiation of Sufentanil Patch Phase II Study by Endo Pharmaceuticals
HSMN NewsFeed - 27 Jun 2007
Aspreva and Roche announce preliminary results for phase III study evaluating CellCept in lupus nephritis
Aspreva and Roche announce preliminary results for phase III study evaluating CellCept in lupus nephritis
HSMN NewsFeed - 27 Jun 2007
CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
HSMN NewsFeed - 27 Jun 2007
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
HSMN NewsFeed - 27 Jun 2007
SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement
SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement
HSMN NewsFeed - 27 Jun 2007
YM BioSciences Receives FDA Clearance for an IND for its Fentanyl-Based Pain Product AeroLEF(TM)
YM BioSciences Receives FDA Clearance for an IND for its Fentanyl-Based Pain Product AeroLEF(TM)
HSMN NewsFeed - 27 Jun 2007
Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
HSMN NewsFeed - 26 Jun 2007
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
HSMN NewsFeed - 26 Jun 2007
Robert J. Levenson Elected to the Board of Directors of Elite Pharmaceuticals, Inc.
Robert J. Levenson Elected to the Board of Directors of Elite Pharmaceuticals, Inc.
HSMN NewsFeed - 26 Jun 2007
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
HSMN NewsFeed - 26 Jun 2007
Teva Announces Approval of Ondansetron HCl Tablets and Ondansetron Orally Disintegrating Tablets USP
Teva Announces Approval of Ondansetron HCl Tablets and Ondansetron Orally Disintegrating Tablets USP
HSMN NewsFeed - 26 Jun 2007
Merrimack Pharmaceuticals Names Lisa Evren Senior Vice President and Chief Financial Officer
Merrimack Pharmaceuticals Names Lisa Evren Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 26 Jun 2007
Lev Pharmaceuticals, Inc. Announces Completion of Marketing and Sales Management Team
Lev Pharmaceuticals, Inc. Announces Completion of Marketing and Sales Management Team
HSMN NewsFeed - 26 Jun 2007
Medical University of South Carolina Initiates New Trial of Cotara(R) in Brain Cancer Patients
Medical University of South Carolina Initiates New Trial of Cotara(R) in Brain Cancer Patients
HSMN NewsFeed - 26 Jun 2007
Auriga Laboratories Appoints Leonhard Dreimann and Thomas Heck to its Board of Directors
Auriga Laboratories Appoints Leonhard Dreimann and Thomas Heck to its Board of Directors
HSMN NewsFeed - 26 Jun 2007
GPC Biotech Announces that Partner Pharmion Submits European Marketing Application for Satraplatin
GPC Biotech Announces that Partner Pharmion Submits European Marketing Application for Satraplatin
HSMN NewsFeed - 26 Jun 2007
UCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II Development for Multiple Sclerosis
UCB and Biogen Idec's Oral VLA-4 Antagonist Enters Phase II Development for Multiple Sclerosis
HSMN NewsFeed - 25 Jun 2007
Encysive Pharmaceuticals Appoints New Chief Executive and Announces Restructuring of Company Operations
Encysive Pharmaceuticals Appoints New Chief Executive and Announces Restructuring of Company Operations
HSMN NewsFeed - 25 Jun 2007
Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial
Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial
HSMN NewsFeed - 25 Jun 2007
GPC Biotech Announces Partnering Agreement for Satraplatin for Japan with Yakult
GPC Biotech Announces Partnering Agreement for Satraplatin for Japan with Yakult
HSMN NewsFeed - 23 Jun 2007
SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
HSMN NewsFeed - 22 Jun 2007
Tramiprosate (ALZHEMED(TM)) North American Phase III clinical trial progress update
Tramiprosate (ALZHEMED(TM)) North American Phase III clinical trial progress update
HSMN NewsFeed - 22 Jun 2007
FDA Approves Carnitor(R) SF (Levocarnitine) Sugar-Free Oral Solution For Patients With Carnitine Deficiency
FDA Approves Carnitor(R) SF (Levocarnitine) Sugar-Free Oral Solution For Patients With Carnitine Deficiency
HSMN NewsFeed - 22 Jun 2007
SkyePharma Inc., Now a Private Pharmaceutical Company, Announces Name Change to Pacira Pharmaceuticals, Inc.
SkyePharma Inc., Now a Private Pharmaceutical Company, Announces Name Change to Pacira Pharmaceuticals, Inc.
HSMN NewsFeed - 22 Jun 2007
TransOral Pharmaceuticals, Inc. Changes Name to Transcept Pharmaceuticals, Inc.
TransOral Pharmaceuticals, Inc. Changes Name to Transcept Pharmaceuticals, Inc.
HSMN NewsFeed - 22 Jun 2007
FDA Approves Novartis Consumer Health, Inc.'s Over-the-Counter THRIVE(TM) Gum for Cessation of Smoking
FDA Approves Novartis Consumer Health, Inc.'s Over-the-Counter THRIVE(TM) Gum for Cessation of Smoking
HSMN NewsFeed - 22 Jun 2007
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH
HSMN NewsFeed - 21 Jun 2007
Pfizer's Lyrica Receives FDA Approval for Fibromyalgia Based on Expedited Review
Pfizer's Lyrica Receives FDA Approval for Fibromyalgia Based on Expedited Review
HSMN NewsFeed - 21 Jun 2007
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
LAB International licenses Fentanyl TAIFUN(R) to Janssen Pharmaceutica NV for Europe
HSMN NewsFeed - 21 Jun 2007
LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation
LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation
HSMN NewsFeed - 21 Jun 2007
VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa, a Treatment for Obesity
VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa, a Treatment for Obesity
HSMN NewsFeed - 21 Jun 2007
King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R)
King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R)
HSMN NewsFeed - 21 Jun 2007
Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
HSMN NewsFeed - 20 Jun 2007
Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL(R)
Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL(R)
HSMN NewsFeed - 20 Jun 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Amlodipine Besylate Tablets
Ranbaxy Receives Tentative Approval to Manufacture and Market Amlodipine Besylate Tablets
HSMN NewsFeed - 19 Jun 2007
Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix Patent Litigation
Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix Patent Litigation
HSMN NewsFeed - 19 Jun 2007
Eurand's Zentase(TM) Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
Eurand's Zentase(TM) Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
HSMN NewsFeed - 19 Jun 2007
Cytokinetics Announces Second Extension of Research Term Under Collaboration With GlaxoSmithKline
Cytokinetics Announces Second Extension of Research Term Under Collaboration With GlaxoSmithKline
HSMN NewsFeed - 19 Jun 2007
Novalar Announces Acceptance of NV-101 New Drug Application for Filing by FDA
Novalar Announces Acceptance of NV-101 New Drug Application for Filing by FDA
HSMN NewsFeed - 19 Jun 2007
REVLIMID(R) Granted Full Marketing Authorization for Treatment of Multiple Myeloma in the European Union
REVLIMID(R) Granted Full Marketing Authorization for Treatment of Multiple Myeloma in the European Union
HSMN NewsFeed - 19 Jun 2007
OSI Pharmaceuticals Begins Clinical Development Program of OSI-906 in Patients with Advanced Solid Tumors
OSI Pharmaceuticals Begins Clinical Development Program of OSI-906 in Patients with Advanced Solid Tumors
HSMN NewsFeed - 19 Jun 2007
FDA Grants Priority Review for Bristol-Myers Squibb's Investigational Oncology Treatment Ixabepilone
FDA Grants Priority Review for Bristol-Myers Squibb's Investigational Oncology Treatment Ixabepilone
HSMN NewsFeed - 19 Jun 2007
Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia
Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia
HSMN NewsFeed - 19 Jun 2007
Organon's Once-a-Month Contraceptive Ring, NuvaRing(R) Completes European Authorization
Organon's Once-a-Month Contraceptive Ring, NuvaRing(R) Completes European Authorization
HSMN NewsFeed - 18 Jun 2007
Health Canada approves new chemotherapy treatment for patients with metastatic colorectal cancer
Health Canada approves new chemotherapy treatment for patients with metastatic colorectal cancer
HSMN NewsFeed - 18 Jun 2007
Gene Logic Collaboration Reveals Genomic Predictors of Parkinson's Disease
Gene Logic Collaboration Reveals Genomic Predictors of Parkinson's Disease
HSMN NewsFeed - 18 Jun 2007
Oculus Innovative Sciences Appoints Vice President of Regulatory Affairs and Quality
Oculus Innovative Sciences Appoints Vice President of Regulatory Affairs and Quality
HSMN NewsFeed - 18 Jun 2007
CoMentis Receives FDA Clearance to Begin Human Clinical Trials for Its Disease-Modifying Alzheimer's Therapy
CoMentis Receives FDA Clearance to Begin Human Clinical Trials for Its Disease-Modifying Alzheimer's Therapy
HSMN NewsFeed - 18 Jun 2007
Vegenics Licenses From CoGenesys Antibodies Against VEGF-C for Applications Including Oncology
Vegenics Licenses From CoGenesys Antibodies Against VEGF-C for Applications Including Oncology
HSMN NewsFeed - 18 Jun 2007
Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
HSMN NewsFeed - 15 Jun 2007
Former President and CEO of Biomira Alex McPherson Joins Carrington Board of Directors
Former President and CEO of Biomira Alex McPherson Joins Carrington Board of Directors
HSMN NewsFeed - 15 Jun 2007
Rexahn Pharmaceuticals, Inc. Appoints Dr. Freddie Ann Hoffman to the Board of Directors
Rexahn Pharmaceuticals, Inc. Appoints Dr. Freddie Ann Hoffman to the Board of Directors
HSMN NewsFeed - 14 Jun 2007
DUSA Pharmaceuticals, Inc. Elects Robert F. Doman as Chief Executive Officer
DUSA Pharmaceuticals, Inc. Elects Robert F. Doman as Chief Executive Officer
HSMN NewsFeed - 14 Jun 2007
Shire's ELAPRASE(TM) (idursulfase) Approved by Health Canada for Treatment of Hunter Syndrome
Shire's ELAPRASE(TM) (idursulfase) Approved by Health Canada for Treatment of Hunter Syndrome
HSMN NewsFeed - 14 Jun 2007
Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in Lamellar Ichthyosis
Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in Lamellar Ichthyosis
HSMN NewsFeed - 14 Jun 2007
CIMZIA(TM) Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
CIMZIA(TM) Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
HSMN NewsFeed - 13 Jun 2007
OSI Pharmaceuticals Announces the Election of Kenneth B. Lee, Jr. to Its Board
OSI Pharmaceuticals Announces the Election of Kenneth B. Lee, Jr. to Its Board
HSMN NewsFeed - 13 Jun 2007
Affymax(R) Announces Resignation of Elizabeth A. Czerepak From its Board of Directors
Affymax(R) Announces Resignation of Elizabeth A. Czerepak From its Board of Directors
HSMN NewsFeed - 13 Jun 2007
GlaxoSmithKline to Make Unprecedented Vaccine Donation to WHO Pandemic Flu Stockpile
GlaxoSmithKline to Make Unprecedented Vaccine Donation to WHO Pandemic Flu Stockpile
HSMN NewsFeed - 13 Jun 2007
Logical Therapeutics Inc. Raises US $30M Series B to Advance Drug Pipeline Targeting Inflammatory Diseases
Logical Therapeutics Inc. Raises US $30M Series B to Advance Drug Pipeline Targeting Inflammatory Diseases
HSMN NewsFeed - 13 Jun 2007
Dale M. Edgar, Ph.D., to Join Lilly; Will Head Lilly Research Lab's Discovery Sleep Research Efforts
Dale M. Edgar, Ph.D., to Join Lilly; Will Head Lilly Research Lab's Discovery Sleep Research Efforts
HSMN NewsFeed - 13 Jun 2007
ARIAD Announces Appointment of Senior Oncology Executive to Leadership Team
ARIAD Announces Appointment of Senior Oncology Executive to Leadership Team
HSMN NewsFeed - 12 Jun 2007
Neurocrine Announces Resubmission of New Drug Application for Indiplon Capsules
Neurocrine Announces Resubmission of New Drug Application for Indiplon Capsules
HSMN NewsFeed - 12 Jun 2007
William D. Perez of Wm. Wrigley Jr. Company Appointed to Johnson & Johnson Board of Directors
William D. Perez of Wm. Wrigley Jr. Company Appointed to Johnson & Johnson Board of Directors
HSMN NewsFeed - 12 Jun 2007
Sherlene Bagley Named Director, Portfolio Development for HEALTHPOINT, Ltd.
Sherlene Bagley Named Director, Portfolio Development for HEALTHPOINT, Ltd.
HSMN NewsFeed - 12 Jun 2007
CEL-SCI Receives US FDA Orphan Drug Designation for Its Cancer Drug Multikine(R)
CEL-SCI Receives US FDA Orphan Drug Designation for Its Cancer Drug Multikine(R)
HSMN NewsFeed - 12 Jun 2007
Metabasis Therapeutics Announces Election of George F. Schreiner to Its Board of Directors
Metabasis Therapeutics Announces Election of George F. Schreiner to Its Board of Directors
HSMN NewsFeed - 12 Jun 2007
Immtech and Par Enter Licensing Agreement on Pafuramidine for Treatment of Pneumocystis Pneumonia
Immtech and Par Enter Licensing Agreement on Pafuramidine for Treatment of Pneumocystis Pneumonia
HSMN NewsFeed - 12 Jun 2007
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
HSMN NewsFeed - 11 Jun 2007
PDI Appoints Nancy Connelly Senior Vice President, Sales Support Services
PDI Appoints Nancy Connelly Senior Vice President, Sales Support Services
HSMN NewsFeed - 11 Jun 2007
NeurogesX Completes Enrollment in Phase 3 Clinical Trial for Postherpetic Neuralgia
NeurogesX Completes Enrollment in Phase 3 Clinical Trial for Postherpetic Neuralgia
HSMN NewsFeed - 11 Jun 2007
Altus Pharmaceuticals Reacquires European Development and Commercialization Rights to ALTU-135
Altus Pharmaceuticals Reacquires European Development and Commercialization Rights to ALTU-135
HSMN NewsFeed - 11 Jun 2007
Progen Expands Senior Management Team with Addition of Two Biopharmaceutical Industry Veterans
Progen Expands Senior Management Team with Addition of Two Biopharmaceutical Industry Veterans
HSMN NewsFeed - 11 Jun 2007
Cytogen Announces New Sales and Marketing Leadership with the Appointment of Stephen A. Ross
Cytogen Announces New Sales and Marketing Leadership with the Appointment of Stephen A. Ross
HSMN NewsFeed - 11 Jun 2007
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
Archemix and Takeda to Enter into Collaboration for Discovery and Development of Aptamer Therapeutics
HSMN NewsFeed - 11 Jun 2007
GSK and Adolor Update Alvimopan (Entereg/Entrareg(R)) Development Program
GSK and Adolor Update Alvimopan (Entereg/Entrareg(R)) Development Program
HSMN NewsFeed - 11 Jun 2007
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients
HSMN NewsFeed - 8 Jun 2007
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
HSMN NewsFeed - 8 Jun 2007
Scios Announces Enrollment of First Patients in ASCEND-HF Trial in Acute Heart Failure
Scios Announces Enrollment of First Patients in ASCEND-HF Trial in Acute Heart Failure
HSMN NewsFeed - 7 Jun 2007
Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease
Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease
HSMN NewsFeed - 7 Jun 2007
Raymond Tesi, M.D., F.A.C.S. Joins Coronado Biosciences as President and Chief Executive Officer
Raymond Tesi, M.D., F.A.C.S. Joins Coronado Biosciences as President and Chief Executive Officer
HSMN NewsFeed - 7 Jun 2007
Eli Lilly and Company Comments on Recent Court Rulings Regarding Zyprexa(R) Patents
Eli Lilly and Company Comments on Recent Court Rulings Regarding Zyprexa(R) Patents
HSMN NewsFeed - 7 Jun 2007
Zogenix Appoints David Nassif Executive Vice President and Chief Financial Officer
Zogenix Appoints David Nassif Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 7 Jun 2007
Par Pharmaceutical Names Gerard A. Martino EVP and COO, Veronica A. Lubatkin EVP and CFO
Par Pharmaceutical Names Gerard A. Martino EVP and COO, Veronica A. Lubatkin EVP and CFO
HSMN NewsFeed - 7 Jun 2007
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
Patrick Gallagher Joins Acusphere as Senior Vice President, Business Development
HSMN NewsFeed - 7 Jun 2007
Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn's Disease
Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn's Disease
HSMN NewsFeed - 7 Jun 2007
Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
HSMN NewsFeed - 7 Jun 2007
Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon(R)
Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon(R)
HSMN NewsFeed - 7 Jun 2007
Labopharm Initiates Phase III Clinical Study for Once-Daily Formulation of Trazodone
Labopharm Initiates Phase III Clinical Study for Once-Daily Formulation of Trazodone
HSMN NewsFeed - 6 Jun 2007
Aspreva announces Fast-Track designation granted by the FDA for CellCept in lupus nephritis
Aspreva announces Fast-Track designation granted by the FDA for CellCept in lupus nephritis
HSMN NewsFeed - 6 Jun 2007
Statement of Moncef Slaoui, PhD, Chairman Research & Development GlaxoSmithKline
Statement of Moncef Slaoui, PhD, Chairman Research & Development GlaxoSmithKline
HSMN NewsFeed - 6 Jun 2007
Newly Published Data From Large Study Support Cardiovascular Safety of Avandia (rosiglitazone maleate)
Newly Published Data From Large Study Support Cardiovascular Safety of Avandia (rosiglitazone maleate)
HSMN NewsFeed - 6 Jun 2007
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
HSMN NewsFeed - 6 Jun 2007
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
HSMN NewsFeed - 6 Jun 2007
Clinical Results From EntreMed's Panzem(R) NCD and Taxol(R) Breast Cancer Study Presented at ASCO
Clinical Results From EntreMed's Panzem(R) NCD and Taxol(R) Breast Cancer Study Presented at ASCO
HSMN NewsFeed - 6 Jun 2007
Acorda Therapeutics Begins Second Phase 3 Clinical Trial of Fampridine-SR in Multiple Sclerosis
Acorda Therapeutics Begins Second Phase 3 Clinical Trial of Fampridine-SR in Multiple Sclerosis
HSMN NewsFeed - 6 Jun 2007
COPAXONE(R) Pre-Filled Syringe Can Now Be Stored for up to One Month at Room Temperature
COPAXONE(R) Pre-Filled Syringe Can Now Be Stored for up to One Month at Room Temperature
HSMN NewsFeed - 5 Jun 2007
VIA Pharmaceuticals and Corautus Genetics Complete Merger to Form VIA Pharmaceuticals, Inc.
VIA Pharmaceuticals and Corautus Genetics Complete Merger to Form VIA Pharmaceuticals, Inc.
HSMN NewsFeed - 5 Jun 2007
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
Extensive Clinical Data on ERBITUX(R) Presented at the 2007 ASCO Annual Meeting
HSMN NewsFeed - 5 Jun 2007
Aradigm Names D. Jeffery Grimes as General Counsel and Corporate Secretary
Aradigm Names D. Jeffery Grimes as General Counsel and Corporate Secretary
HSMN NewsFeed - 4 Jun 2007
Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related Proposals
Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related Proposals
HSMN NewsFeed - 4 Jun 2007
NUCRYST Pharmaceuticals appoints Edward Gaj Jr. Vice President, Corporate Development
NUCRYST Pharmaceuticals appoints Edward Gaj Jr. Vice President, Corporate Development
HSMN NewsFeed - 4 Jun 2007
Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac(R) Weekly(TM)
Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac(R) Weekly(TM)
HSMN NewsFeed - 4 Jun 2007
Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
HSMN NewsFeed - 4 Jun 2007
Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
HSMN NewsFeed - 4 Jun 2007
Avid Radiopharmaceuticals Appoints Ernest Mario, Ph.D. to Board of Directors
Avid Radiopharmaceuticals Appoints Ernest Mario, Ph.D. to Board of Directors
HSMN NewsFeed - 4 Jun 2007
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
HSMN NewsFeed - 4 Jun 2007
Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia
Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia
HSMN NewsFeed - 4 Jun 2007
Trius Therapeutics Recruits Merck Executive to Lead Drug Development Efforts
Trius Therapeutics Recruits Merck Executive to Lead Drug Development Efforts
HSMN NewsFeed - 4 Jun 2007
EntreMed Presents Phase 2 Results for Panzem(R) Capsules in Multiple Myeloma
EntreMed Presents Phase 2 Results for Panzem(R) Capsules in Multiple Myeloma
HSMN NewsFeed - 4 Jun 2007
Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
HSMN NewsFeed - 4 Jun 2007
YM BioSciences Cleared to Initiate Clinical trial of Nimotuzumab in Colorectal Cancer
YM BioSciences Cleared to Initiate Clinical trial of Nimotuzumab in Colorectal Cancer
HSMN NewsFeed - 3 Jun 2007
Next Generation of Investigational Anti-Cancer Agents Unveiled at ASCO by AstraZeneca
Next Generation of Investigational Anti-Cancer Agents Unveiled at ASCO by AstraZeneca
HSMN NewsFeed - 3 Jun 2007
Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
HSMN NewsFeed - 3 Jun 2007
Xeloda(R) Plus Avastin(R) Combination Delays Disease Progression in Women with Advanced Breast Cancer
Xeloda(R) Plus Avastin(R) Combination Delays Disease Progression in Women with Advanced Breast Cancer
HSMN NewsFeed - 3 Jun 2007
Constab Pharmaceutical Develops New Tool to Treat Metastatic Colorectal and Other Cancers
Constab Pharmaceutical Develops New Tool to Treat Metastatic Colorectal and Other Cancers
HSMN NewsFeed - 3 Jun 2007
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
HSMN NewsFeed - 3 Jun 2007
Exelixis Reports Integrated Data From Phase II Clinical Trials of XL999 at ASCO
Exelixis Reports Integrated Data From Phase II Clinical Trials of XL999 at ASCO
HSMN NewsFeed - 3 Jun 2007
Xanthus Announces Phase 1 Results for P2045 - a Targeted Agent for Non-Small Cell Lung Cancer
Xanthus Announces Phase 1 Results for P2045 - a Targeted Agent for Non-Small Cell Lung Cancer
HSMN NewsFeed - 2 Jun 2007
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
HSMN NewsFeed - 2 Jun 2007
New Data Evaluating SUTENT, CP-751,871 and Axitinib in Patients with Non-Small Cell Lung Cancer
New Data Evaluating SUTENT, CP-751,871 and Axitinib in Patients with Non-Small Cell Lung Cancer
HSMN NewsFeed - 2 Jun 2007
Biweekly Xeloda(R) Dosing Regimen is Well Tolerated in Advanced Breast Cancer
Biweekly Xeloda(R) Dosing Regimen is Well Tolerated in Advanced Breast Cancer
HSMN NewsFeed - 2 Jun 2007
Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer
Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer
HSMN NewsFeed - 2 Jun 2007
Xanthus Presents Phase 2 Data Showing Xanafide is Associated with Complete Remissions in Secondary AML
Xanthus Presents Phase 2 Data Showing Xanafide is Associated with Complete Remissions in Secondary AML
HSMN NewsFeed - 1 Jun 2007
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
HSMN NewsFeed - 1 Jun 2007
Semafore Pharmaceuticals Appoints Dr. Ullrich Schwertschlag Chief Medical Officer
Semafore Pharmaceuticals Appoints Dr. Ullrich Schwertschlag Chief Medical Officer
HSMN NewsFeed - 31 May 2007
Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol
Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol
HSMN NewsFeed - 31 May 2007
Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
HSMN NewsFeed - 31 May 2007
AVANIR Receives FDA Approval for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
AVANIR Receives FDA Approval for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
HSMN NewsFeed - 31 May 2007
Dr. Todd Johnson Joins MDS Pharma Services as Senior Vice-President for Strategy and Corporate Development
Dr. Todd Johnson Joins MDS Pharma Services as Senior Vice-President for Strategy and Corporate Development
HSMN NewsFeed - 31 May 2007
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
HSMN NewsFeed - 31 May 2007
Halozyme Therapeutics Announces Closing of $32.1 Million Private Financing
Halozyme Therapeutics Announces Closing of $32.1 Million Private Financing
HSMN NewsFeed - 31 May 2007
Ception Therapeutics Raises Additional $14.7 Million Bringing Total Series C Financing to $77 Million
Ception Therapeutics Raises Additional $14.7 Million Bringing Total Series C Financing to $77 Million
HSMN NewsFeed - 31 May 2007
Rob Frankenberg, Ph.D. Joins Bionovo as Vice President of Drug Manufacturing
Rob Frankenberg, Ph.D. Joins Bionovo as Vice President of Drug Manufacturing
HSMN NewsFeed - 31 May 2007
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
HSMN NewsFeed - 31 May 2007
FDA Approves Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Asthma
FDA Approves Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Asthma
HSMN NewsFeed - 30 May 2007
FDA Approves TORISEL, a Targeted First-in-Class mTOR Inhibitor for the Treatment of Advanced Kidney Cancer
FDA Approves TORISEL, a Targeted First-in-Class mTOR Inhibitor for the Treatment of Advanced Kidney Cancer
HSMN NewsFeed - 30 May 2007
Canadian Health Authority Approves THELIN (Sitaxsentan Sodium) for Pulmonary Arterial Hypertension
Canadian Health Authority Approves THELIN (Sitaxsentan Sodium) for Pulmonary Arterial Hypertension
HSMN NewsFeed - 30 May 2007
Data Affirms Avandia (Rosiglitazone maleate) Cardiovascular Safety Profile
Data Affirms Avandia (Rosiglitazone maleate) Cardiovascular Safety Profile
HSMN NewsFeed - 30 May 2007
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec(R)
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec(R)
HSMN NewsFeed - 30 May 2007
Novalar Hires Vice President of Marketing to Direct Launch of Anesthetic Reversal Agent NV-101
Novalar Hires Vice President of Marketing to Direct Launch of Anesthetic Reversal Agent NV-101
HSMN NewsFeed - 29 May 2007
IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
HSMN NewsFeed - 29 May 2007
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program
HSMN NewsFeed - 29 May 2007
Hi-Tech Pharmacal Settles Litigation with MedPointe and JFC Technologies, Acquires Vosol(R) Product Line
Hi-Tech Pharmacal Settles Litigation with MedPointe and JFC Technologies, Acquires Vosol(R) Product Line
HSMN NewsFeed - 29 May 2007
DRAXIS Appoints Bruce DeChambre to Head Business Development for Contract Manufacturing Division
DRAXIS Appoints Bruce DeChambre to Head Business Development for Contract Manufacturing Division
HSMN NewsFeed - 29 May 2007
Positive Final Data from HyCAMP(TM) Phase II Trial in Metastatic Colorectal Cancer
Positive Final Data from HyCAMP(TM) Phase II Trial in Metastatic Colorectal Cancer
HSMN NewsFeed - 29 May 2007
EntreMed Commences Phase 2 Clinical Trial Combining Panzem(R) NCD and Temodar(R) in Brain Cancer Patients
EntreMed Commences Phase 2 Clinical Trial Combining Panzem(R) NCD and Temodar(R) in Brain Cancer Patients
HSMN NewsFeed - 29 May 2007
QLT USA, Inc. files Aczone(TM) labeling supplement for removal of blood screening requirement
QLT USA, Inc. files Aczone(TM) labeling supplement for removal of blood screening requirement
